Rebounding from last week's losses, the ALS Ltd (ASX: ALQ) share price is heading north on Monday.
At the time of writing, the testing services company's shares are swapping hands at $10.36, up 1.97%.
For context, the S&P/ASX 200 Index (ASX: XJO) is 0.97% higher following a strong finish by Wall Street on Friday.
ALS insider buying action continues
In light of the recent slump, the company's non-executive director, John Mulcahy recently took advantage of ALS's share price weakness.
In a statement to the ASX, the company advised that Mulcahy purchased 25,000 ALS shares at a price of $10.276 apiece. This was conducted via an on-market trade on 14 July by Mulcahy's indirect interest, Juntos Investments Pty Ltd.
The transaction equates to the value of $256,900.
Following the latest purchase, this means that Mulcahy now holds a total of 79,027 ALS indirect shares across his holdings.
The buy-in comes after another insider, non-executive Leslie Desjardins, picked up 6,800 ALS shares in late May.
It seems that some members of the board believe that ALS shares are trading at bargain levels for the moment.
It is worth noting that the ALS share price touched a 52-week low of $9.96 on 13 July before slightly recovering lost ground today.
This is a sharp contrast from when it was trading at a year-to-date high of $13.76 on 5 April.
ALS share price summary
Despite today's gain, the ALS share price has fallen by 17% in the past 12 months.
In 2022, its shares are down 20%.
Based on today's price, ALS presides a market capitalisation of approximately $4.92 billion.
